(Circulation. 1997;96:137-147.)
© 1997 American Heart Association, Inc.
Articles |
Cardiac Imaging for Risk Stratification With Dobutamine-Atropine Stress Testing in Patients With Chest Pain
Echocardiography, Perfusion Scintigraphy, or Both?
From the Thoraxcenter and the Department of Nuclear Medicine, University Hospital, Rotterdam-Dijkzigt and Erasmus University, Rotterdam, Netherlands.
Correspondence to Marcel L. Geleijnse, MD, Thoraxcentre, Ba 300, Dr Molewaterplein 40, 3015 GD Rotterdam, Netherlands.
Background Pharmacological stress echocardiography and myocardial perfusion scintigraphy are used frequently for risk stratification in patients with suspected myocardial ischemia. However, their relative prognostic strength has never been explored.
Methods and Results Two hundred twenty consecutive patients
with chest pain (mean age, 60±12 years; 124 men, 115 with previous
myocardial infarction) were studied with
dobutamine-atropine stress
echocardiography (ECHO) and
simultaneous 99mTc sestamibi single photon
emission computed tomography imaging (MIBI). Ischemia was
defined as deterioration in left ventricular wall motion
and reversible perfusion defects, respectively. ECHO was positive for
ischemia in 76 and MIBI in 91 patients (agreement, 77%;
=.51). During follow-up of 31±15 months, 24 patients had hard
cardiac events (nonfatal myocardial infarction or cardiac death). By
univariate analysis, age, history of congestive
heart failure, and any abnormality or ischemia on ECHO or MIBI
were associated with cardiac events. Multivariate
analysis revealed that age, abnormal ECHO (odds ratio [OR],
18.9; 95% CI, 2.5 to 146.0) or MIBI (OR, 12.8; 95% CI, 1.7 to 98.3),
and ischemia on ECHO (OR, 4.0; 95% CI, 1.6 to 9.9) or MIBI
(OR, 3.0; 95% CI, 1.2 to 7.4) had independent predictive values. When
ECHO was used as a first option, the addition of MIBI to all
nonischemic ECHO studies decreased the OR from 4.0 (95% CI,
1.6 to 9.9) to 3.8 (95% CI, 1.4 to 10.2). Addition of MIBI confined to
nonischemic ECHO studies in which target heart rate was not
attained (nondiagnostic studies) increased the OR to a
maximal 5.7 (95% CI, 2.2 to 15.0). In contrast, the addition of ECHO
to nondiagnostic MIBI studies was not useful.
Conclusions Dobutamine-atropine ECHO and MIBI provide comparable prognostic information. The addition of MIBI to ECHO may be useful in patients with nondiagnostic ECHO studies.
Key Words: stress • tests • echocardiography • radioisotopes • prognosis
This article has been cited by other articles:
 |
|
 |
|
  R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC) Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381. [Full Text] [PDF]
|
|
|
|
 |
|
 D H Hsi, A Roshandel, N Singh, T Szombathy, and Z S Meszaros Headache response to glyceryl trinitrate in patients with and without obstructive coronary artery disease Heart, September 1, 2005; 91(9): 1164 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. Armstrong and W. A. Zoghbi Stress Echocardiography: Current Methodology and Clinical Applications J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1739 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Senior, M Monaghan, H Becher, J Mayet, and P Nihoyannopoulos Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: a critical appraisal. Supported by the British Society of Echocardiography Heart, April 1, 2005; 91(4): 427 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Acampa, L. Spinelli, M. Petretta, F. De Lauro, F. Ibello, and A. Cuocolo Prognostic Value of Myocardial Ischemia in Patients with Uncomplicated Acute Myocardial Infarction: Direct Comparison of Stress Echocardiography and Myocardial Perfusion Imaging J. Nucl. Med., March 1, 2005; 46(3): 417 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Mieres, L. J. Shaw, A. Arai, M. J. Budoff, S. D. Flamm, W. G. Hundley, T. H. Marwick, L. Mosca, A. R. Patel, M. A. Quinones, et al. Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Coronary Artery Disease: Consensus Statement From the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association Circulation, February 8, 2005; 111(5): 682 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Elhendy, E. L. O'Leary, F. Xie, A. C. McGrain, J. R. Anderson, and T. R. Porter Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2185 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Labib, M. Goldstein, P. M. Kinnunen, and E. C. Schick Cardiac events in patients with negative maximal versus negative submaximal dobutamine echocardiograms undergoing noncardiac surgery: Importance of resting wall motion abnormalities J. Am. Coll. Cardiol., July 7, 2004; 44(1): 82 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.F.L Schinkel, J.J Bax, M.L Geleijnse, E Boersma, A Elhendy, J.R.T.C Roelandt, and D Poldermans Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur. Heart J., May 1, 2003; 24(9): 789 - 800. [Full Text] [PDF]
|
|
|
|
|
|
A. Elhendy, J. J. Bax, and D. Poldermans Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease J. Nucl. Med., December 1, 2002; 43(12): 1634 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F.L. Schinkel, A. Elhendy, R. T. van Domburg, J. J. Bax, J. R.T.C. Roelandt, and D. Poldermans Prognostic Value of Dobutamine-Atropine Stress 99mTc-Tetrofosmin Myocardial Perfusion SPECT in Patients with Known or Suspected Coronary Artery Disease J. Nucl. Med., June 1, 2002; 43(6): 767 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tadamura, H. Iida, K. Matsumoto, M. Mamede, S. Kubo, H. Toyoda, T. Shiozaki, T. Mukai, Y. Magata, and J. Konishi Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men J. Am. Coll. Cardiol., January 1, 2001; 37(1): 130 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Geleijnse, A. Elhendy, P. M. Fioretti, and J. R. T. C. Roelandt Dobutamine stress myocardial perfusion imaging J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2017 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.L Geleijnse, A Elhendy, J.D Kasprzak, R Rambaldi, R.T Van Domburg, J.H Cornel, A.P.J Klootwijk, P.M Fioretti, J.R.T.C Roelandt, and M.L Simoons Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram Eur. Heart J., March 1, 2000; 21(5): 397 - 406. [Abstract] [PDF]
|
|
|
|
|
|
A Elhendy, R T van Domburg, J J Bax, D Poldermans, P R Nierop, M L Geleijnse, and J R T C Roelandt The grade of worsening of regional function during dobutamine stress echocardiography predicts the extent of myocardial perfusion abnormalities Heart, January 1, 2000; 83(1): 35 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Krivokapich, J. S. Child, D. O. Walter, and A. Garfinkel Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease J. Am. Coll. Cardiol., March 1, 1999; 33(3): 708 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Poldermans, P. M. Fioretti, E. Boersma, J. J. Bax, I. R. Thomson, J. R. T. C. Roelandt, and M. L. Simoons Long-Term Prognostic Value of Dobutamine-Atropine Stress Echocardiography in 1737 Patients With Known or Suspected Coronary Artery Disease : A Single-Center Experience Circulation, February 16, 1999; 99(6): 757 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ferrari, B.a. Schnell, G. S. Werner, and H. R. Figulla Safety of deferring angioplasty in patients with normal coronary flow velocity reserve J. Am. Coll. Cardiol., January 1, 1999; 33(1): 82 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J A S. Román, I Vilacosta, J A Castillo, M J Rollán, M Hernández, V Peral, I Garcimartín, M d. M. de la Torre, and F Fernández-Avilés Selection of the optimal stress test for the diagnosis of coronary artery disease Heart, October 1, 1998; 80(4): 370 - 376. [Abstract] [Full Text]
|
|